387 related articles for article (PubMed ID: 18445640)
1. Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice.
Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
Nephrol Dial Transplant; 2008 Sep; 23(9):2768-76. PubMed ID: 18445640
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice.
Lui SL; Yung S; Tsang R; Zhang F; Chan KW; Tam S; Chan TM
Lupus; 2008 Apr; 17(4):305-13. PubMed ID: 18413412
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin attenuates the severity of murine adriamycin nephropathy.
Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
Am J Nephrol; 2009; 29(4):342-52. PubMed ID: 18948688
[TBL] [Abstract][Full Text] [Related]
4. Prevention of murine lupus disease in (NZBxNZW)F1 mice by sirolimus treatment.
Ramos-Barrón A; Piñera-Haces C; Gómez-Alamillo C; Santiuste-Torcida I; Ruiz JC; Buelta-Carrillo L; Merino R; de Francisco AL; Arias M
Lupus; 2007; 16(10):775-81. PubMed ID: 17895299
[TBL] [Abstract][Full Text] [Related]
5. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
6. CCR1 inhibition ameliorates the progression of lupus nephritis in NZB/W mice.
Bignon A; Gaudin F; Hémon P; Tharinger H; Mayol K; Walzer T; Loetscher P; Peuchmaur M; Berrebi D; Balabanian K
J Immunol; 2014 Feb; 192(3):886-96. PubMed ID: 24367031
[TBL] [Abstract][Full Text] [Related]
7. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE
Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
[TBL] [Abstract][Full Text] [Related]
8. Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.
Jongstra-Bilen J; Vukusic B; Boras K; Wither JE
J Immunol; 1997 Dec; 159(12):5810-20. PubMed ID: 9550377
[TBL] [Abstract][Full Text] [Related]
9. Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis.
Quezada SA; Eckert M; Adeyi OA; Schned AR; Noelle RJ; Burns CM
Arthritis Rheum; 2003 Sep; 48(9):2541-54. PubMed ID: 13130474
[TBL] [Abstract][Full Text] [Related]
10. Effect of rapamycin on renal ischemia-reperfusion injury in mice.
Lui SL; Chan KW; Tsang R; Yung S; Lai KN; Chan TM
Transpl Int; 2006 Oct; 19(10):834-9. PubMed ID: 16961776
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function.
Kalled SL; Cutler AH; Datta SK; Thomas DW
J Immunol; 1998 Mar; 160(5):2158-65. PubMed ID: 9498753
[TBL] [Abstract][Full Text] [Related]
12. Prevention of renal damage in murine lupus nephritis by CTLA-4Ig and cyclophosphamide.
Cunnane G; Chan OT; Cassafer G; Brindis S; Kaufman E; Yen TS; Daikh DI
Arthritis Rheum; 2004 May; 50(5):1539-48. PubMed ID: 15146424
[TBL] [Abstract][Full Text] [Related]
13. Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice.
Zykova SN; Seredkina N; Benjaminsen J; Rekvig OP
Arthritis Rheum; 2008 Mar; 58(3):813-25. PubMed ID: 18311834
[TBL] [Abstract][Full Text] [Related]
14. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.
Nozaki Y; Yamagata T; Yoo BS; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M; Kanamaru A
Clin Exp Immunol; 2005 Jan; 139(1):74-83. PubMed ID: 15606616
[TBL] [Abstract][Full Text] [Related]
15. Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model.
Ko E; Lee Y; Park N; Cho C; Yim YN; Kim J; Kim YS; Kim D; Shin MK; Hong MC; Bae H
Lupus; 2007; 16(5):335-41. PubMed ID: 17576735
[TBL] [Abstract][Full Text] [Related]
16. Effect of mycophenolate and rapamycin on renal fibrosis in lupus nephritis.
Zhang C; Chan CCY; Cheung KF; Chau MKM; Yap DYH; Ma MKM; Chan KW; Yung S; Chan TM
Clin Sci (Lond); 2019 Aug; 133(15):1721-1744. PubMed ID: 31358596
[TBL] [Abstract][Full Text] [Related]
17. New immunosuppresor strategies in the treatment of murine lupus nephritis.
Alperovich G; Rama I; Lloberas N; Franquesa M; Poveda R; Gomà M; Herrero-Fresneda I; Cruzado JM; Bolaños N; Carrera M; Grinyó JM; Torras J
Lupus; 2007; 16(1):18-24. PubMed ID: 17283580
[TBL] [Abstract][Full Text] [Related]
18. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
[TBL] [Abstract][Full Text] [Related]
19. Curcumin attenuates lupus nephritis upon interaction with regulatory T cells in New Zealand Black/White mice.
Lee H; Kim H; Lee G; Chung HS; Bae H
Br J Nutr; 2013 Jul; 110(1):69-76. PubMed ID: 23181951
[TBL] [Abstract][Full Text] [Related]
20. Effects of delayed rapamycin treatment on renal fibrosis and inflammation in experimental ischemia reperfusion injury.
Liu M; Agreda P; Crow M; Racusen L; Rabb H
Transplant Proc; 2009 Dec; 41(10):4065-71. PubMed ID: 20005342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
